首页> 美国卫生研究院文献>BMC Ophthalmology >A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration

【2h】

A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration

机译：一种评估基于实践的过程和结果数据的系统方法该方法可用于治疗新血管性年龄相关性黄斑变性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Flow Chart of the Selection Process of Patients , neovascular age-related macular degeneration; , fluorescein angiography; number of patients; , Verteporfin photodynamic therapy

机译：新血管性年龄相关性黄斑变性患者选择过程的流程图；，荧光素血管造影；患者人数；，维替泊芬光动力疗法

著录项

期刊名称 BMC Ophthalmology
作者
Margriet I. van der Reis; M. Elshout; Tos T. J. M. Berendschot; Yvonne de Jong-Hesse; Carroll A. B. Webers; Jan S. A. G. Schouten;
展开▼
作者单位

展开▼
年(卷),期 2020(20),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类眼科学;
关键词
Age-related macular degeneration; outcome study; visual acuity; Anti-VEGF; Ranibizumab; Bevacizumab; Photodynamic therapy;

机译：年龄相关性黄斑变性;结果研究;视力;抗-VEGF;雷珠单抗;贝伐单抗;光动力疗法;

相似文献

外文文献
中文文献
专利

1. A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration [J] . Margriet I. van der Reis, M. Elshout, Tos T. J. M. Berendschot, BMC Ophthalmology . 2020,第1期

机译：一种评估基于实践的过程和结果数据的系统方法，应用于治疗新生血管年龄相关的黄斑变性
2. Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data [J] . Kanda Koji, Sato Tomohito, Taguchi Manzo, Investigative ophthalmology & visual science . 2017,第8期

机译：根据固定的2个月间隔接受AfliBercept的眼睛两年的结果与新生血管年龄相关的黄斑变性：观察研究DataTwo岁月后的眼睛，接受AfliBercept的目的，根据固定的2个月的新生血管年龄相关性黄斑变性：观察研究数据
3. Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data [J] . Kanda Koji, Sato Tomohito, Taguchi Manzo, Investigative ophthalmology & visual science . 2017,第8期

机译：根据固定的2个月间隔接受AfliBercept的眼睛两年的结果与新生血管年龄相关的黄斑变性：观察研究DataTwo岁月后的眼睛，接受AfliBercept的目的，根据固定的2个月的新生血管年龄相关性黄斑变性：观察研究数据
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Synthesis of Nonretinoid Inhibitors of RPE65 for the Potential Treatment of Dry Age-Related Macular Degeneration and Stargardt Disease [D] . Wang, Ivan E. 2020

机译：RPE65的非素脂抑制剂的合成潜在治疗干龄相关性黄斑和晕术病
6. A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept [O] . Sophie Seguin-Greenstein, Sue Lightman, Oren Tomkins-Netzer 2016

机译：评估抗拒新血管性年龄相关性黄斑变性患者转用阿柏西普治疗后视觉和解剖学结局评估研究的荟萃分析
7. The macular threshold protocol of the Humphrey visual field analyzer: a superior functional outcome of intravitreal bevacizumab for the treatment of neovascular age-related macular degeneration Desfecho funcional superior da eficácia do tratamento com bevacizumab intravítreo em degeneração macular relacionada à idade, por meio do protocolo de limiar macular do campímetro de Humphrey [O] . Fabio Lavinsky, Micheal John Tolentino, Jaco Lavinsky 2010

机译：Humphrey视野分析仪的黄斑阈值方案：玻璃体内贝伐单抗治疗新生血管性年龄相关性黄斑变性的优越功能结果玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性的功效优于humphrey的黄斑门槛

A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration

摘要

著录项

相似文献

相关主题

期刊订阅